risks of glp-1 GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment GLP-1 medication side effects for

The most widely used weight loss injections are GLP-1 receptor agonists , a class of drugs originally developed for diabetes

A new study published in ACR Open Rheumatology Journal looked at patients with RA who began treatment with a GLP-1 agonist, either semaglutide or tirzepatide, for obesity

P values are calculated by multi-parametric two-way ANOVA

Tran KL, Park YI, Pandya S, et al

The jury is out at the moment, but their potential to be differentiated from injectable peptides is clear and seems likely to drive significant research into small molecule modulators of GLP-1 for the treatment of diabetes, obesity and perhaps addictive behaviours for many years to come.

Kim KM, Noh JH, Bodogai M, et al